首页 > 最新文献

Thrombosis最新文献

英文 中文
Pathogenesis of Thromboembolism and Endovascular Management 血栓栓塞的发病机制和血管内治疗
Pub Date : 2017-01-05 DOI: 10.1155/2017/3039713
Sasan Behravesh, Peter Hoang, A. Nanda, A. Wallace, R. Sheth, A. Deipolyi, Adnan Memić, S. Naidu, R. Oklu
Venous thromboembolism (VTE), a disease that includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is associated with high mortality, morbidity, and costs. It can result in long-term complications that include postthrombotic syndrome (PTS) adding to its morbidity. VTE affects 1/1000 patients, costs $13.5 billion annually to treat, and claims 100,000 lives annually in the US. The current standard of care for VTE is anticoagulation, though thrombolysis may be performed in patients with PE and threatened limb. This review discusses pathogenesis and medical treatment of VTE and then focuses on endovascular treatment modalities. Mechanical- and catheter-directed thrombolysis (CDT) is discussed, as well as patient selection criteria, and complications. The first prospective study (CaVenT) comparing CDT with anticoagulation alone in acute DVT, despite study shortcomings, corroborates the existing literature indicating improved outcomes with CDT. The potential of the ongoing prospective, multicenter, randomized ATTRACT trial is also highlighted.
静脉血栓栓塞(VTE)是一种包括深静脉血栓形成(DVT)和肺栓塞(PE)的疾病,具有高死亡率、高发病率和高费用。它可导致长期并发症,包括血栓后综合征(PTS)增加其发病率。静脉血栓栓塞患者占1/1000,每年治疗费用为135亿美元,在美国每年夺去10万人的生命。目前静脉血栓栓塞的标准治疗是抗凝治疗,尽管对于PE和威胁肢体的患者可以进行溶栓治疗。本文就静脉血栓栓塞的发病机制和药物治疗进行综述,并重点介绍血管内治疗方法。机械和导管定向溶栓(CDT)的讨论,以及患者的选择标准,和并发症。第一项前瞻性研究(CaVenT)比较了CDT与单独抗凝治疗急性DVT,尽管研究存在缺陷,但证实了现有文献表明CDT可改善预后。正在进行的前瞻性、多中心、随机吸引试验的潜力也得到了强调。
{"title":"Pathogenesis of Thromboembolism and Endovascular Management","authors":"Sasan Behravesh, Peter Hoang, A. Nanda, A. Wallace, R. Sheth, A. Deipolyi, Adnan Memić, S. Naidu, R. Oklu","doi":"10.1155/2017/3039713","DOIUrl":"https://doi.org/10.1155/2017/3039713","url":null,"abstract":"Venous thromboembolism (VTE), a disease that includes deep venous thrombosis (DVT) and pulmonary embolism (PE), is associated with high mortality, morbidity, and costs. It can result in long-term complications that include postthrombotic syndrome (PTS) adding to its morbidity. VTE affects 1/1000 patients, costs $13.5 billion annually to treat, and claims 100,000 lives annually in the US. The current standard of care for VTE is anticoagulation, though thrombolysis may be performed in patients with PE and threatened limb. This review discusses pathogenesis and medical treatment of VTE and then focuses on endovascular treatment modalities. Mechanical- and catheter-directed thrombolysis (CDT) is discussed, as well as patient selection criteria, and complications. The first prospective study (CaVenT) comparing CDT with anticoagulation alone in acute DVT, despite study shortcomings, corroborates the existing literature indicating improved outcomes with CDT. The potential of the ongoing prospective, multicenter, randomized ATTRACT trial is also highlighted.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2017-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78118991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 34
Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary Embolism. 肺显像在急性肺栓塞诊断中的转诊模式和诊断率。
Pub Date : 2017-01-01 Epub Date: 2017-04-11 DOI: 10.1155/2017/1623868
Matthieu Pelletier-Galarneau, Erik Zannier, Lionel S Zuckier, Gregoire Le Gal

Introduction. The purpose of this study is to assess referral patterns and the yield of ventilation-perfusion (V/Q) scintigraphy in patients referred for acute pulmonary embolism (PE). Methods. We retrospectively reviewed the charts of all patients who underwent V/Q studies between April 1, 2008, and March 31, 2010. Patients were subdivided into 4 groups based on their referral source: emergency department (ED), hospital inpatient ward, outpatient thrombosis clinic, and all other outpatient sources. Results. A total of 1008 patients underwent V/Q scintigraphy to exclude acute PE. The number of ED, inpatient, thrombosis clinic, and outpatient studies was 43 (4.3%), 288 (28.6%), 351 (34.8%), and 326 (32.3%). Proportion of patients with contrast contraindication varied significantly among the different groups. Of the 1,008 studies, 331 (32.8%) were interpreted as normal, 408 (40.5%) as low, 158 (15.7%) as intermediate, and 111 (11.0%) as high probability for PE. 68 (6.7%) patients underwent CTPA within 2 weeks following V/Q. Conclusion. The rate of nondiagnostic studies is lower than that reported in previously published data, with a relatively low rate of intermediate probability studies. Only a small fraction of patients undergoing a V/Q scan will require a CTPA.

介绍。本研究的目的是评估转诊模式和急性肺栓塞(PE)患者的通气灌注(V/Q)闪烁成像的产量。方法。我们回顾性地回顾了2008年4月1日至2010年3月31日期间接受V/Q研究的所有患者的图表。根据转诊来源将患者细分为4组:急诊科(ED)、医院住院病房、门诊血栓门诊和所有其他门诊来源。结果。1008例患者接受了V/Q显像以排除急性PE。急诊、住院、血栓临床和门诊研究分别为43例(4.3%)、288例(28.6%)、351例(34.8%)和326例(32.3%)。对比禁忌症患者比例在不同组间差异显著。在1008个研究中,331个(32.8%)被解释为正常,408个(40.5%)被解释为低概率,158个(15.7%)被解释为中等概率,111个(11.0%)被解释为高概率PE。68例(6.7%)患者在V/Q后2周内行CTPA。结论。非诊断性研究的比率低于先前发表的数据,中间概率研究的比率相对较低。只有一小部分接受V/Q扫描的患者需要CTPA。
{"title":"Referral Patterns and Diagnostic Yield of Lung Scintigraphy in the Diagnosis of Acute Pulmonary Embolism.","authors":"Matthieu Pelletier-Galarneau,&nbsp;Erik Zannier,&nbsp;Lionel S Zuckier,&nbsp;Gregoire Le Gal","doi":"10.1155/2017/1623868","DOIUrl":"https://doi.org/10.1155/2017/1623868","url":null,"abstract":"<p><p><i>Introduction</i>. The purpose of this study is to assess referral patterns and the yield of ventilation-perfusion (V/Q) scintigraphy in patients referred for acute pulmonary embolism (PE). <i>Methods</i>. We retrospectively reviewed the charts of all patients who underwent V/Q studies between April 1, 2008, and March 31, 2010. Patients were subdivided into 4 groups based on their referral source: emergency department (ED), hospital inpatient ward, outpatient thrombosis clinic, and all other outpatient sources. <i>Results</i>. A total of 1008 patients underwent V/Q scintigraphy to exclude acute PE. The number of ED, inpatient, thrombosis clinic, and outpatient studies was 43 (4.3%), 288 (28.6%), 351 (34.8%), and 326 (32.3%). Proportion of patients with contrast contraindication varied significantly among the different groups. Of the 1,008 studies, 331 (32.8%) were interpreted as normal, 408 (40.5%) as low, 158 (15.7%) as intermediate, and 111 (11.0%) as high probability for PE. 68 (6.7%) patients underwent CTPA within 2 weeks following V/Q. <i>Conclusion</i>. The rate of nondiagnostic studies is lower than that reported in previously published data, with a relatively low rate of intermediate probability studies. Only a small fraction of patients undergoing a V/Q scan will require a CTPA.</p>","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"2017 ","pages":"1623868"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1623868","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34985396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells. 活化的人外周血单核细胞中miR-19a、miR-20a与组织因子的表达
Pub Date : 2017-01-01 Epub Date: 2017-10-30 DOI: 10.1155/2017/1076397
Cristina Balia, Mirella Giordano, Valentina Scalise, Tommaso Neri, Gabriella Fontanini, Fulvio Basolo, Alessandro Celi, Roberto Pedrinelli

Background and aims: To investigate the behaviour of miR-19a and miR-20a, two microRNAs involved in posttranscriptional modulation of TF expression in peripheral blood mononuclear cells (PBMCs) exposed to high glucose (HG) and lipopolysaccharide (LPS), and to evaluate the involvement of angiotensin II in that process.

Methods: TF Procoagulant Activity (PCA, one-stage clotting assay), antigen (Ag, ELISA), and miR-19a and miR-20a levels (specific TaqMan® MicroRNA Assays) were evaluated in PBMCs exposed to high glucose (HG, 50 mM), LPS (100 ng/mL), and Olmesartan (OLM, 10-6 M), an angiotensin II type 1 receptor antagonist.

Results: HG increased TF expression and decreased both miRs as compared to control glucose conditions (11.1 mM). In HG-activated PBMCs, LPS stimulated TF expression and downregulated miR-20a, an effect reverted by OLM (10-6 M); miR-19a expression was unchanged by LPS in both CG and HG conditions.

Conclusions: miR-19a and miR-20a are inhibited by inflammatory stimuli active on TF expression and their response differs by the stimulus under investigation; angiotensin II may participate in that mechanism.

背景和目的:研究暴露于高糖(HG)和脂多糖(LPS)的外周血单个核细胞(PBMCs)中参与TF转录后调控的miR-19a和miR-20a的行为,并评估血管紧张素II在这一过程中的作用。方法:在暴露于高糖(HG, 50 mM), LPS (100 ng/mL)和Olmesartan (10-6 M)(一种血管紧张素II型1受体拮抗剂)的PBMCs中,评估TF促凝活性(PCA,一阶段凝血试验),抗原(Ag, ELISA), miR-19a和miR-20a水平(特异性TaqMan®MicroRNA测定)。结果:与对照血糖(11.1 mM)相比,HG增加了TF表达,降低了两种miRs。在hg激活的PBMCs中,LPS刺激TF表达并下调miR-20a, OLM可以逆转这一作用(10-6 M);在CG和HG条件下,LPS均未改变miR-19a的表达。结论:miR-19a和miR-20a可被激活TF表达的炎症刺激抑制,且其反应因刺激的不同而不同;血管紧张素II可能参与了这一机制。
{"title":"miR-19a and miR-20a and Tissue Factor Expression in Activated Human Peripheral Blood Mononuclear Cells.","authors":"Cristina Balia,&nbsp;Mirella Giordano,&nbsp;Valentina Scalise,&nbsp;Tommaso Neri,&nbsp;Gabriella Fontanini,&nbsp;Fulvio Basolo,&nbsp;Alessandro Celi,&nbsp;Roberto Pedrinelli","doi":"10.1155/2017/1076397","DOIUrl":"https://doi.org/10.1155/2017/1076397","url":null,"abstract":"<p><strong>Background and aims: </strong>To investigate the behaviour of miR-19a and miR-20a, two microRNAs involved in posttranscriptional modulation of TF expression in peripheral blood mononuclear cells (PBMCs) exposed to high glucose (HG) and lipopolysaccharide (LPS), and to evaluate the involvement of angiotensin II in that process.</p><p><strong>Methods: </strong>TF Procoagulant Activity (PCA, one-stage clotting assay), antigen (Ag, ELISA), and miR-19a and miR-20a levels (specific TaqMan® MicroRNA Assays) were evaluated in PBMCs exposed to high glucose (HG, 50 mM), LPS (100 ng/mL), and Olmesartan (OLM, 10<sup>-6</sup> M), an angiotensin II type 1 receptor antagonist.</p><p><strong>Results: </strong>HG increased TF expression and decreased both miRs as compared to control glucose conditions (11.1 mM). In HG-activated PBMCs, LPS stimulated TF expression and downregulated miR-20a, an effect reverted by OLM (10<sup>-6</sup> M); miR-19a expression was unchanged by LPS in both CG and HG conditions.</p><p><strong>Conclusions: </strong>miR-19a and miR-20a are inhibited by inflammatory stimuli active on TF expression and their response differs by the stimulus under investigation; angiotensin II may participate in that mechanism.</p>","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"2017 ","pages":"1076397"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1076397","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35228570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases 具有抗血小板特性的草药对冠状动脉粥样硬化性疾病有益
Pub Date : 2016-03-14 DOI: 10.1155/2016/5952910
N. H. Mohd Nor, F. Othman, Eusni Rahayu Mohd Tohit, S. Md Noor
Coronary atherothrombotic diseases such as coronary artery disease, peripheral vascular disease, cerebrovascular disease, and heart failure are the serious concerns of the thrombus formed in blood vessels. Anticoagulant and antiplatelet drugs are the cornerstones of the management of these diseases. To prevent the recurrence of these diseases, double antiplatelet drugs such as aspirin and clopidogrel has been the standard management in most hospitals. However, aspirin resistance and clopidogrel inefficient effects due to noncompliance with double drugs regimen can cause a sinister effect on patients. Medicinal plants serve as a greater resource for new medication and their potential currently became a topic of interest to the researchers all over the world. Traditionally, certain herbs have been used as a treatment for heart diseases but have been investigated for their antiplatelet properties. This current review explained few traditional antithrombotic herbals and their antiplatelet properties in vitro and in vivo and this is to be deeply discussed in further research.
冠状动脉粥样硬化性疾病,如冠状动脉疾病、外周血管疾病、脑血管疾病和心力衰竭,是血管内形成血栓的严重问题。抗凝血和抗血小板药物是治疗这些疾病的基石。为了防止这些疾病的复发,阿司匹林和氯吡格雷等双重抗血小板药物已成为大多数医院的标准管理。然而,由于不遵守双药方案,阿司匹林耐药性和氯吡格雷无效效应会对患者造成不良影响。药用植物是开发新药的重要资源,其潜力已成为世界各国研究人员关注的热点。传统上,某些草药已被用作治疗心脏病,但已调查其抗血小板特性。本文综述了几种传统抗血栓药物及其体内体外抗血小板性能,有待进一步深入研究。
{"title":"Medicinal Herbals with Antiplatelet Properties Benefit in Coronary Atherothrombotic Diseases","authors":"N. H. Mohd Nor, F. Othman, Eusni Rahayu Mohd Tohit, S. Md Noor","doi":"10.1155/2016/5952910","DOIUrl":"https://doi.org/10.1155/2016/5952910","url":null,"abstract":"Coronary atherothrombotic diseases such as coronary artery disease, peripheral vascular disease, cerebrovascular disease, and heart failure are the serious concerns of the thrombus formed in blood vessels. Anticoagulant and antiplatelet drugs are the cornerstones of the management of these diseases. To prevent the recurrence of these diseases, double antiplatelet drugs such as aspirin and clopidogrel has been the standard management in most hospitals. However, aspirin resistance and clopidogrel inefficient effects due to noncompliance with double drugs regimen can cause a sinister effect on patients. Medicinal plants serve as a greater resource for new medication and their potential currently became a topic of interest to the researchers all over the world. Traditionally, certain herbs have been used as a treatment for heart diseases but have been investigated for their antiplatelet properties. This current review explained few traditional antithrombotic herbals and their antiplatelet properties in vitro and in vivo and this is to be deeply discussed in further research.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"51 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80926753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
The Incidence of Peripheral Catheter-Related Thrombosis in Surgical Patients 手术患者外周导管相关血栓的发生率
Pub Date : 2016-01-24 DOI: 10.1155/2016/6043427
Amy Leung, C. Heal, Jennifer Banks, Breanna Abraham, Gianmarco Capati, C. Pretorius
Background. Central venous catheters and peripherally inserted central catheters are well established risk factors for upper limb deep vein thrombosis. There is limited literature on the thrombosis rates in patients with peripheral catheters. A prospective observational study was conducted to determine the incidence of peripheral catheter-related thrombosis in surgical patients. Methods. Patients deemed high risk for venous thrombosis with a peripheral catheter were considered eligible for the study. An ultrasound was performed on enrolment into the study and at discharge from hospital. Participants were reviewed twice a day for clinical features of upper limb deep vein thrombosis during their admission and followed up at 30 days. Results. 54 patients were included in the study. The incidence of deep vein thrombosis and superficial venous thrombosis was 1.8% and 9.2%, respectively. All cases of venous thrombosis were asymptomatic. Risk factor analysis was limited by the low incidence of thrombosis. Conclusion. This study revealed a low incidence of deep vein thrombosis in surgical patients with peripheral catheters (1.8%). The study was underpowered; therefore the association between peripheral catheters and thrombosis is unable to be established. Future studies with larger sample sizes are required to determine the association between peripheral catheters and thrombosis.
背景。中心静脉置管和外周中心置管是上肢深静脉血栓形成的危险因素。关于外周导管患者血栓形成率的文献有限。进行了一项前瞻性观察研究,以确定手术患者外周导管相关血栓的发生率。方法。被认为有静脉血栓形成高风险的外周导管患者被认为有资格参加这项研究。在入组时和出院时进行超声检查。入院期间,每天两次对参与者进行上肢深静脉血栓形成的临床特征评估,并在30天后进行随访。结果:54例患者纳入研究。深静脉血栓和浅静脉血栓的发生率分别为1.8%和9.2%。静脉血栓形成均无症状。血栓发生率低限制了危险因素分析。结论。本研究显示外周置管手术患者深静脉血栓的发生率较低(1.8%)。这项研究的动力不足;因此,外周导管与血栓形成之间的关联无法建立。未来需要更大样本量的研究来确定外周导管与血栓形成之间的关系。
{"title":"The Incidence of Peripheral Catheter-Related Thrombosis in Surgical Patients","authors":"Amy Leung, C. Heal, Jennifer Banks, Breanna Abraham, Gianmarco Capati, C. Pretorius","doi":"10.1155/2016/6043427","DOIUrl":"https://doi.org/10.1155/2016/6043427","url":null,"abstract":"Background. Central venous catheters and peripherally inserted central catheters are well established risk factors for upper limb deep vein thrombosis. There is limited literature on the thrombosis rates in patients with peripheral catheters. A prospective observational study was conducted to determine the incidence of peripheral catheter-related thrombosis in surgical patients. Methods. Patients deemed high risk for venous thrombosis with a peripheral catheter were considered eligible for the study. An ultrasound was performed on enrolment into the study and at discharge from hospital. Participants were reviewed twice a day for clinical features of upper limb deep vein thrombosis during their admission and followed up at 30 days. Results. 54 patients were included in the study. The incidence of deep vein thrombosis and superficial venous thrombosis was 1.8% and 9.2%, respectively. All cases of venous thrombosis were asymptomatic. Risk factor analysis was limited by the low incidence of thrombosis. Conclusion. This study revealed a low incidence of deep vein thrombosis in surgical patients with peripheral catheters (1.8%). The study was underpowered; therefore the association between peripheral catheters and thrombosis is unable to be established. Future studies with larger sample sizes are required to determine the association between peripheral catheters and thrombosis.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89537558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
The Typical Presentation Spectrum of Deep Vein Thrombosis Associated with Inferior Vena Cava Malformations. 与下腔静脉畸形相关的深静脉血栓的典型表现谱。
Pub Date : 2016-01-01 Epub Date: 2016-07-10 DOI: 10.1155/2016/4965458
Agostino Pozzi, Mustapha A El Lakis, Jad Chamieh, Beatriz Barberà Carbonell, Fabio Villa

Congenital malformations of the inferior vena cava (IVC) are rare and underreported. They can be a risk factor for deep venous thrombosis (DVT) as a result of inadequate venous drainage of the lower extremities through collateral circulation. The significant number of cases reported in the literature highlights their importance, warranting investigating their existence in younger individuals with idiopathic DVT of the lower extremities and pelvic veins. In this systematic review, we depict the typical presentation of IVC malformations, their management, and the management of their associated DVT.

下腔静脉(IVC)先天性畸形非常罕见,而且报告不足。下腔静脉畸形可能是深静脉血栓形成(DVT)的危险因素,因为下肢静脉通过侧支循环引流不足。文献中报道的大量病例凸显了其重要性,因此有必要对下肢和骨盆静脉特发性深静脉血栓形成的年轻患者进行调查。在这篇系统性综述中,我们描述了 IVC 畸形的典型表现、处理方法以及相关深静脉血栓的处理方法。
{"title":"The Typical Presentation Spectrum of Deep Vein Thrombosis Associated with Inferior Vena Cava Malformations.","authors":"Agostino Pozzi, Mustapha A El Lakis, Jad Chamieh, Beatriz Barberà Carbonell, Fabio Villa","doi":"10.1155/2016/4965458","DOIUrl":"10.1155/2016/4965458","url":null,"abstract":"<p><p>Congenital malformations of the inferior vena cava (IVC) are rare and underreported. They can be a risk factor for deep venous thrombosis (DVT) as a result of inadequate venous drainage of the lower extremities through collateral circulation. The significant number of cases reported in the literature highlights their importance, warranting investigating their existence in younger individuals with idiopathic DVT of the lower extremities and pelvic veins. In this systematic review, we depict the typical presentation of IVC malformations, their management, and the management of their associated DVT. </p>","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"2016 ","pages":"4965458"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958425/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34721618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out of Sight, out of Mind? An Audit Which Proposes a Follow-Up and Management Pathway for Inferior Vena Cava Filters. 眼不见,心不烦?下腔静脉过滤器的审计及后续处理途径。
Pub Date : 2016-01-01 Epub Date: 2016-03-27 DOI: 10.1155/2016/6538456
Caitriona Logan, Niamh O'Connell, John Kavanagh, Niall McEniff, Mark Ryan, Michael Guiney, Orla Seery, James O'Donnell, Kevin Ryan, Barry White

Insertion of an IVC filter can be a safe and effective way to avoid PE in thrombosis patients who cannot be anticoagulated. If temporary filters are not promptly removed they can become difficult to remove, causing avoidable complications and often requiring lifelong warfarin. In this study, two sequential audits of retrieval of temporary IVC filters were conducted before and after the implementation of a coordinated management strategy for IVC filter follow-up. 33 filter placements were examined over a 15-month period (Group A). Following implementation of the strategy a comparable 15-month period in which 33 IVC filters were placed was audited (Group B). Following implementation, failed retrievals dropped from 15% to 9%. The number successfully retrieved did not change at 45%. The number made permanent from the outset following expert discussion increased from 12% to 39%. The number of filters with no attempted retrieval and no consultation about retrieval decreased from 27% to 9% (these patients were lost to follow-up with multiple contact attempts made). In Group B 100% of placed IVC filters were followed up appropriately. The proposed model is an easily implemented plan to avoid patient morbidity caused by temporary IVC filters made unintentionally permanent by loss to follow-up.

对于不能抗凝治疗的血栓患者,置入下腔静脉滤过器是一种安全有效的避免PE的方法。如果不及时清除临时过滤器,它们会变得难以清除,导致可避免的并发症,通常需要终身使用华法林。在本研究中,在实施IVC过滤器随访协调管理策略之前和之后,对临时IVC过滤器的检索进行了两次连续审计。在15个月的时间内检查了33个过滤器的放置情况(a组)。在实施该策略后的15个月内,对33个IVC过滤器进行了审计(B组)。实施后,失败的检索从15%下降到9%。成功检索的数量保持在45%不变。经过专家讨论,从一开始就被定为永久性的人数从12%增加到39%。未尝试取取和未咨询取取的患者数量从27%下降到9%(这些患者因多次接触尝试而失去随访)。B组对100%放置的IVC滤器进行适当随访。所提出的模型是一个易于实施的计划,以避免由于失去随访而使临时IVC过滤器无意中成为永久性的患者发病率。
{"title":"Out of Sight, out of Mind? An Audit Which Proposes a Follow-Up and Management Pathway for Inferior Vena Cava Filters.","authors":"Caitriona Logan,&nbsp;Niamh O'Connell,&nbsp;John Kavanagh,&nbsp;Niall McEniff,&nbsp;Mark Ryan,&nbsp;Michael Guiney,&nbsp;Orla Seery,&nbsp;James O'Donnell,&nbsp;Kevin Ryan,&nbsp;Barry White","doi":"10.1155/2016/6538456","DOIUrl":"https://doi.org/10.1155/2016/6538456","url":null,"abstract":"<p><p>Insertion of an IVC filter can be a safe and effective way to avoid PE in thrombosis patients who cannot be anticoagulated. If temporary filters are not promptly removed they can become difficult to remove, causing avoidable complications and often requiring lifelong warfarin. In this study, two sequential audits of retrieval of temporary IVC filters were conducted before and after the implementation of a coordinated management strategy for IVC filter follow-up. 33 filter placements were examined over a 15-month period (Group A). Following implementation of the strategy a comparable 15-month period in which 33 IVC filters were placed was audited (Group B). Following implementation, failed retrievals dropped from 15% to 9%. The number successfully retrieved did not change at 45%. The number made permanent from the outset following expert discussion increased from 12% to 39%. The number of filters with no attempted retrieval and no consultation about retrieval decreased from 27% to 9% (these patients were lost to follow-up with multiple contact attempts made). In Group B 100% of placed IVC filters were followed up appropriately. The proposed model is an easily implemented plan to avoid patient morbidity caused by temporary IVC filters made unintentionally permanent by loss to follow-up. </p>","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"2016 ","pages":"6538456"},"PeriodicalIF":0.0,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2016/6538456","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34429116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study 利伐沙班和华法林治疗肺栓塞的住院时间比较:来自真实世界观察队列研究的结果
Pub Date : 2015-12-31 DOI: 10.1155/2015/414523
K. Roberts, Tamara B Knight, Eimeira Padilla-Tolentino, Manasa S. Murthy, Evan J. Peterson
Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not been performed outside post hoc analysis of a large clinical trial. Objective. To evaluate if rivaroxaban decreases length of stay compared to warfarin plus enoxaparin in the treatment of PE. Methods. This was a multicenter, retrospective, observational cohort study. Patients were identified based on discharge diagnosis of PE and were excluded if they received anticoagulants prior to admission and had additional indications for anticoagulation or reduced creatinine clearance. The primary endpoint was length of stay. Secondary endpoints included time from initial dose of oral anticoagulant to discharge and length of stay comparison between subgroups. Results. Inclusion criterion was met by 158 patients (82 warfarin, 76 rivaroxaban). The median length of stay was 4.5 days (interquartile range [IQR], 2.7, 5.9) in the warfarin group and 1.8 days (IQR, 1.2, 3.7) in the rivaroxaban group (P < 0.001). Time interval from first dose of oral anticoagulant to discharge was shorter with rivaroxaban (P < 0.001). Conclusions. Patients given rivaroxaban had decreased length of stay versus those given warfarin plus enoxaparin for the treatment of PE.
背景。试验表明,与华法林相比,新型口服抗凝剂可缩短住院时间。除了对一项大型临床试验的事后分析外,还没有对肺栓塞(PE)治疗的住院时间进行比较。目标。评价与华法林加依诺肝素治疗PE相比,利伐沙班是否能缩短住院时间。方法。这是一项多中心、回顾性、观察性队列研究。根据PE的出院诊断确定患者,如果在入院前接受了抗凝治疗,并且有其他抗凝指征或肌酐清除率降低,则排除患者。主要终点是住院时间。次要终点包括从口服抗凝剂初始剂量到出院的时间和亚组间住院时间的比较。结果。158例患者符合纳入标准(华法林82例,利伐沙班76例)。华法林组的中位住院时间为4.5天(四分位数间距[IQR], 2.7, 5.9),利伐沙班组的中位住院时间为1.8天(IQR, 1.2, 3.7) (P < 0.001)。利伐沙班组口服抗凝剂首次给药至出院的时间间隔较短(P < 0.001)。结论。服用利伐沙班的患者与服用华法林加依诺肝素治疗PE的患者相比,住院时间缩短。
{"title":"Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study","authors":"K. Roberts, Tamara B Knight, Eimeira Padilla-Tolentino, Manasa S. Murthy, Evan J. Peterson","doi":"10.1155/2015/414523","DOIUrl":"https://doi.org/10.1155/2015/414523","url":null,"abstract":"Background. Trials have shown that novel oral anticoagulants may decrease length of stay versus warfarin. A comparison of length of stay in the treatment of pulmonary embolism (PE) has not been performed outside post hoc analysis of a large clinical trial. Objective. To evaluate if rivaroxaban decreases length of stay compared to warfarin plus enoxaparin in the treatment of PE. Methods. This was a multicenter, retrospective, observational cohort study. Patients were identified based on discharge diagnosis of PE and were excluded if they received anticoagulants prior to admission and had additional indications for anticoagulation or reduced creatinine clearance. The primary endpoint was length of stay. Secondary endpoints included time from initial dose of oral anticoagulant to discharge and length of stay comparison between subgroups. Results. Inclusion criterion was met by 158 patients (82 warfarin, 76 rivaroxaban). The median length of stay was 4.5 days (interquartile range [IQR], 2.7, 5.9) in the warfarin group and 1.8 days (IQR, 1.2, 3.7) in the rivaroxaban group (P < 0.001). Time interval from first dose of oral anticoagulant to discharge was shorter with rivaroxaban (P < 0.001). Conclusions. Patients given rivaroxaban had decreased length of stay versus those given warfarin plus enoxaparin for the treatment of PE.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"11 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84347805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients 非手术机械通气患者静脉血栓栓塞化学预防与机械预防的比较
Pub Date : 2015-11-22 DOI: 10.1155/2015/849142
Dany Gaspard, K. Vito, C. Schorr, K. Hunter, D. Gerber
Background. Thromboembolic events are major causes of morbidity, and prevention is important. We aimed to compare chemical prophylaxis (CP) and mechanical prophylaxis (MP) as methods of prevention in nonsurgical patients on mechanical ventilation. Methods. We performed a retrospective study of adult patients admitted to the Cooper University Hospital ICU between 2002 and 2010. Patients on one modality of prophylaxis throughout their stay were included. The CP group comprised 329 patients and the MP group 419 patients. The primary outcome was incidence of thromboembolic events. Results. Acuity measured by APACHE II score was comparable between the two groups (p = 0.215). Univariate analysis showed 1 DVT/no PEs in the CP group and 12 DVTs/1 PE in the MP group (p = 0.005). Overall mortality was 34.3% and 50.6%, respectively. ICU LOS was similar. Hospital LOS was shorter in the MP group. Multivariate analysis showed a significantly higher incidence of events in the MP prophylaxis group (odds ratio 9.9). After excluding patients admitted for bleeding in both groups, repeat analysis showed again increased events in the MP group (odds ratio 2.9) but this result did not reach statistical significance. Conclusion. Chemical methods for DVT/PE prophylaxis seem superior to mechanical prophylaxis in nonsurgical patients on mechanical ventilation and should be used when possible.
背景。血栓栓塞事件是发病的主要原因,预防很重要。我们的目的是比较化学预防(CP)和机械预防(MP)作为预防非手术患者机械通气的方法。方法。我们对2002年至2010年间在库珀大学医院ICU住院的成年患者进行了回顾性研究。在整个住院期间采用一种预防方式的患者被纳入。CP组329例,MP组419例。主要终点是血栓栓塞事件的发生率。结果。两组间以APACHE II评分测量的锐度具有可比性(p = 0.215)。单因素分析显示,CP组为1 DVT/no PE, MP组为12 DVT/ 1 PE (p = 0.005)。总死亡率分别为34.3%和50.6%。ICU LOS相似。MP组住院时间较短。多因素分析显示,MP预防组的事件发生率明显更高(优势比9.9)。在排除两组因出血入院的患者后,重复分析显示MP组的事件再次增加(优势比2.9),但该结果未达到统计学意义。结论。在机械通气的非手术患者中,化学方法预防DVT/PE似乎优于机械预防,应尽可能使用。
{"title":"Comparison of Chemical and Mechanical Prophylaxis of Venous Thromboembolism in Nonsurgical Mechanically Ventilated Patients","authors":"Dany Gaspard, K. Vito, C. Schorr, K. Hunter, D. Gerber","doi":"10.1155/2015/849142","DOIUrl":"https://doi.org/10.1155/2015/849142","url":null,"abstract":"Background. Thromboembolic events are major causes of morbidity, and prevention is important. We aimed to compare chemical prophylaxis (CP) and mechanical prophylaxis (MP) as methods of prevention in nonsurgical patients on mechanical ventilation. Methods. We performed a retrospective study of adult patients admitted to the Cooper University Hospital ICU between 2002 and 2010. Patients on one modality of prophylaxis throughout their stay were included. The CP group comprised 329 patients and the MP group 419 patients. The primary outcome was incidence of thromboembolic events. Results. Acuity measured by APACHE II score was comparable between the two groups (p = 0.215). Univariate analysis showed 1 DVT/no PEs in the CP group and 12 DVTs/1 PE in the MP group (p = 0.005). Overall mortality was 34.3% and 50.6%, respectively. ICU LOS was similar. Hospital LOS was shorter in the MP group. Multivariate analysis showed a significantly higher incidence of events in the MP prophylaxis group (odds ratio 9.9). After excluding patients admitted for bleeding in both groups, repeat analysis showed again increased events in the MP group (odds ratio 2.9) but this result did not reach statistical significance. Conclusion. Chemical methods for DVT/PE prophylaxis seem superior to mechanical prophylaxis in nonsurgical patients on mechanical ventilation and should be used when possible.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83471302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
The Perception of Evidence for Venous Thromboembolism Prophylaxis Current Practices after Cardiac Surgery: A Canadian Cross-Sectional Survey 心脏手术后静脉血栓栓塞预防的证据感知:加拿大横断面调查
Pub Date : 2015-11-02 DOI: 10.1155/2015/795645
H. Mufti, R. Baskett, R. Arora, J. Légaré
Background. Venous thromboembolism (VTE) is the third leading cause of cardiovascular death in patients undergoing surgery. However, VTE prophylaxis practices in cardiac surgery are based on noncardiac surgical literature. The objective of our study was to extract current patterns of VTE prophylaxis practices in cardiac surgery patients. We also aimed to identify health care professionals knowledge of available evidence supporting VTE prophylaxis in adult cardiac surgery patients. Methods. A web-based survey was developed and sent to all Canadian cardiac surgery centers with the intent to have the survey distributed to all personnel involved in the perioperative care of adult cardiac surgery patients. Participation in the questionnaire was voluntary and anonymized. Results. Thirty-five responses were obtained. Sixty-nine percent reported having an established protocol for VTE prophylaxis. However, 83% reported using VTE prophylaxis in their daily practice despite lack of protocol. The majority (60%) believed that the class of recommendation was high despite the lack of evidence. Conclusions. Our survey demonstrated the following. (a) Majority of Canadian centers employ VTE prophylaxis, with considerable variability. (b) There is a misconception among health care professionals about the strength of evidence supporting VTE prophylaxis in cardiac surgery. Our findings highlight the need for appropriately designed studies to fill this knowledge gap.
背景。静脉血栓栓塞(VTE)是手术患者心血管死亡的第三大原因。然而,心脏手术中静脉血栓栓塞的预防实践是基于非心脏手术文献。我们研究的目的是提取心脏手术患者静脉血栓栓塞预防实践的当前模式。我们还旨在确定卫生保健专业人员的知识,现有证据支持静脉血栓栓塞预防成人心脏手术患者。方法。开发了一项基于网络的调查,并将其发送到加拿大所有心脏手术中心,目的是将调查分发给所有参与成人心脏手术患者围手术期护理的人员。问卷的参与是自愿和匿名的。结果。共获得35份答复。69%的人报告有静脉血栓栓塞预防的既定方案。然而,83%的人报告在他们的日常实践中使用静脉血栓栓塞预防,尽管缺乏协议。大多数人(60%)认为,尽管缺乏证据,但建议的等级很高。结论。我们的调查证明了以下几点。(a)加拿大大多数中心采用静脉血栓栓塞预防,但差异很大。(b)卫生保健专业人员对心脏手术中支持静脉血栓栓塞预防的证据力度存在误解。我们的研究结果强调需要适当设计的研究来填补这一知识空白。
{"title":"The Perception of Evidence for Venous Thromboembolism Prophylaxis Current Practices after Cardiac Surgery: A Canadian Cross-Sectional Survey","authors":"H. Mufti, R. Baskett, R. Arora, J. Légaré","doi":"10.1155/2015/795645","DOIUrl":"https://doi.org/10.1155/2015/795645","url":null,"abstract":"Background. Venous thromboembolism (VTE) is the third leading cause of cardiovascular death in patients undergoing surgery. However, VTE prophylaxis practices in cardiac surgery are based on noncardiac surgical literature. The objective of our study was to extract current patterns of VTE prophylaxis practices in cardiac surgery patients. We also aimed to identify health care professionals knowledge of available evidence supporting VTE prophylaxis in adult cardiac surgery patients. Methods. A web-based survey was developed and sent to all Canadian cardiac surgery centers with the intent to have the survey distributed to all personnel involved in the perioperative care of adult cardiac surgery patients. Participation in the questionnaire was voluntary and anonymized. Results. Thirty-five responses were obtained. Sixty-nine percent reported having an established protocol for VTE prophylaxis. However, 83% reported using VTE prophylaxis in their daily practice despite lack of protocol. The majority (60%) believed that the class of recommendation was high despite the lack of evidence. Conclusions. Our survey demonstrated the following. (a) Majority of Canadian centers employ VTE prophylaxis, with considerable variability. (b) There is a misconception among health care professionals about the strength of evidence supporting VTE prophylaxis in cardiac surgery. Our findings highlight the need for appropriately designed studies to fill this knowledge gap.","PeriodicalId":75222,"journal":{"name":"Thrombosis","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85241849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Thrombosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1